Panoral Forte

Active Ingredient:: Cefaclor
Origin:: EU

Panoral Forte (Cefaclor)

Q: What is Panoral Forte used for?

Panoral Forte contains cefaclor, a cephalosporin antibiotic used to treat a range of bacterial infections such as ear infections, pneumonia, sinusitis, throat infections, and skin infections when prescribed by a qualified healthcare professional.

Q: How does cefaclor work?

Cefaclor works by binding to bacterial penicillin‑binding proteins, inhibiting the synthesis of the cell wall peptidoglycan layer. This weakens the wall, causing bacterial cells to burst and die, effectively clearing the infection.

Q: What is the usual dose of Panoral Forte?

The dosage of cefaclor in Panoral Forte is determined by the prescribing clinician based on the type and severity of infection, patient age, weight, and kidney function. Patients should follow the prescriber’s instructions exactly.

Q: Is Panoral Forte safe during pregnancy or breastfeeding?

Cefaclor is classified as pregnancy category B in many regions, indicating no proven risk in animal studies but limited human data. It may be used during pregnancy or lactation only if clearly needed and after risk‑benefit assessment by the healthcare provider.

Q: How do I order Panoral Forte from GNH India?

To order Panoral Forte, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Q: How does cefaclor compare with other antibiotics?

Cefaclor is a second‑generation cephalosporin offering broader Gram‑negative coverage than first‑generation agents like cefalexin, while retaining good activity against many Gram‑positive organisms. It is often chosen for mixed infections where both types of bacteria may be present.

Q: What are the storage requirements for Panoral Forte?

Panoral Forte should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children.

Q: How is Panoral Forte administered?

Panoral Forte is taken orally, usually with a glass of water. It may be taken with or without food, but consistency with meals can help reduce gastrointestinal upset. Follow the prescriber’s dosing schedule.

Q: What are the most serious risks associated with cefaclor?

The most serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, Clostridioides difficile‑associated colitis, and rare blood disorders like hemolytic anemia. Immediate medical attention is required if these occur.

Q: Who should not use Panoral Forte?

Panoral Forte should not be used by individuals with a known hypersensitivity to cefaclor, other cephalosporins, or any beta‑lactam antibiotics. It is also contraindicated in neonates and infants younger than three months due to the risk of bilirubin displacement.

Cefaclor, the active ingredient in Panoral Forte, is a cephalosporin presented as an oral tablet for systemic use. It treats bacterial infections in adults and children as prescribed by a healthcare professional.

GNH India supplies Panoral Forte as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Dr. Friedrich Eberth Arzneimittel Gmbh

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cefaclor is indicated for bacterial infections affecting the respiratory and skin pathways.

Acute otitis media: eradicates the causative bacteria and relieves ear pain.
Community‑acquired pneumonia: provides coverage against common respiratory pathogens.
Acute bacterial sinusitis: reduces sinus inflammation and infection.
Pharyngitis/Tonsillitis: clears streptococcal throat infections.
Skin and soft‑tissue infections: treats cellulitis and wound infections caused by susceptible organisms.

How It Works

Cefaclor inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, disrupting peptidoglycan cross‑linking and leading to osmotic lysis of susceptible Gram‑positive and Gram‑negative organisms.

Side Effects

Cefaclor may cause a range of adverse reactions.

Common Side Effects

Nausea: mild to moderate upset stomach.
Diarrhea: loose stools, sometimes watery.
Vomiting: occasional emesis.
Abdominal pain: cramping or discomfort.
Rash: mild skin erythema.
Headache: transient tension‑type pain.

Serious or Rare Side Effects

Anaphylaxis: severe allergic reaction with breathing difficulty.
Stevens‑Johnson syndrome: severe skin blistering.
Clostridioides difficile‑associated diarrhea: colitis after antibiotic use.
Serum sickness‑like reaction: fever, arthralgia, rash.
Hemolytic anemia: reduction in red blood cells.
Elevated liver enzymes: signs of hepatic stress.

Precautions & Warnings

Before prescribing Cefaclor, consider the following safety measures.

Allergy assessment: verify no known hypersensitivity to beta‑lactams.
Renal function: evaluate kidney status, especially in the elderly.
Gastrointestinal disease: use cautiously in patients with colitis history.
Neonates and infants <3 months: avoid due to risk of bilirubin displacement.
Dose adjustment: modify dosage in moderate to severe renal impairment.
Store at room temperature: keep in the original container, protect from moisture.

Avoid Interactions

Cefaclor can interact with several medicines; monitor accordingly.

Major Interactions (Avoid)

Other beta‑lactam antibiotics: antagonistic effect may reduce efficacy.
Probenecid: increases cefaclor plasma concentrations, raising toxicity risk.
Oral anticoagulants: may enhance anticoagulant effect and bleeding.

Moderate Interactions (Monitor Closely)

Oral contraceptives: possible reduction in hormonal effectiveness.
Antacids containing aluminum or magnesium: may decrease cefaclor absorption.
Methotrexate: increased risk of hematologic toxicity.
Diuretics: altered renal excretion may affect drug levels.

Frequently Asked Questions

Panoral Forte contains cefaclor, a cephalosporin antibiotic used to treat a range of bacterial infections such as ear infections, pneumonia, sinusitis, throat infections, and skin infections when prescribed by a qualified healthcare professional.

Cefaclor works by binding to bacterial penicillin‑binding proteins, inhibiting the synthesis of the cell wall peptidoglycan layer. This weakens the wall, causing bacterial cells to burst and die, effectively clearing the infection.

The dosage of cefaclor in Panoral Forte is determined by the prescribing clinician based on the type and severity of infection, patient age, weight, and kidney function. Patients should follow the prescriber’s instructions exactly.

Cefaclor is classified as pregnancy category B in many regions, indicating no proven risk in animal studies but limited human data. It may be used during pregnancy or lactation only if clearly needed and after risk‑benefit assessment by the healthcare provider.

To order Panoral Forte, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Cefaclor is a second‑generation cephalosporin offering broader Gram‑negative coverage than first‑generation agents like cefalexin, while retaining good activity against many Gram‑positive organisms. It is often chosen for mixed infections where both types of bacteria may be present.

Panoral Forte should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children.

Panoral Forte is taken orally, usually with a glass of water. It may be taken with or without food, but consistency with meals can help reduce gastrointestinal upset. Follow the prescriber’s dosing schedule.

The most serious risks include severe allergic reactions such as anaphylaxis, Stevens‑Johnson syndrome or toxic epidermal necrolysis, Clostridioides difficile‑associated colitis, and rare blood disorders like hemolytic anemia. Immediate medical attention is required if these occur.

Panoral Forte should not be used by individuals with a known hypersensitivity to cefaclor, other cephalosporins, or any beta‑lactam antibiotics. It is also contraindicated in neonates and infants younger than three months due to the risk of bilirubin displacement.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 12 Oct 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.